What Is Tesamorelin?
Tesamorelin is a synthetic 44-amino acid peptide analogue of Growth Hormone-Releasing Hormone (GHRH). As one of the most extensively characterized GHRH analogues, Tesamorelin has been studied for its effects on visceral adipose tissue, cognitive function, and body composition.
Mechanism of Action
Tesamorelin activates the GHRH receptor on somatotroph cells in the anterior pituitary, triggering growth hormone release and subsequent hepatic IGF-1 production. The GH-IGF-1 axis affects metabolism, body composition, and cellular growth.
Key Specifications at G25
G25 Tesamorelin is supplied as white lyophilized powder with purity exceeding 99 percent verified by independent HPLC and MS. Available in 5mg and 10mg vials. Store lyophilized at 2 to 8 degrees Celsius.
Research Applications
Tesamorelin supports investigations in visceral adipose tissue reduction, HIV-associated lipodystrophy, cognitive function and neuroprotection, growth hormone axis pharmacology, and body composition research.
Clinical Background
Tesamorelin has been extensively studied for visceral fat reduction, making it one of the most clinically characterized GHRH analogues for research.